Clinical trials sponsored by Verastem, Inc.
3
Recruiting trials
7
Conditions studied
Phase breakdown
Phase 1 1Phase 2 3
Conditions studied
| Condition | Trials |
|---|---|
| Colorectal Cancer | 2 |
| Lung cancer | 2 |
| Non Small Cell Lung Cancer | 2 |
| G12D Mutated KRAS | 1 |
| Pancreatic Ductal Adenocarcinoma | 1 |
| Pancreatic cancer | 1 |
| Solid Tumor, Adult | 1 |
Recruiting trials led by Verastem, Inc.
- A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
- A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
Common questions
How many trials is Verastem, Inc. recruiting for?
Verastem, Inc. is the lead sponsor of 3 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.